128 related articles for article (PubMed ID: 10336272)
1. Hormonal therapy after stem cell transplantation and risk of veno-occlusive disease.
Sica S; Salutari P; Chiusolo P; Cicconi S; Sorá F; Laurenti L; Piccirillo N; Scirpa P; Leone G
Blood; 1999 May; 93(9):3154. PubMed ID: 10336272
[No Abstract] [Full Text] [Related]
2. Luteinizing hormone-releasing hormone analogue: leuprorelin acetate for the prevention of menstrual bleeding in premenopausal women undergoing stem cell transplantation.
Chiusolo P; Salutari P; Sica S; Scirpa P; Laurenti L; Piccirillo N; Leone G
Bone Marrow Transplant; 1998 Apr; 21(8):821-3. PubMed ID: 9603407
[TBL] [Abstract][Full Text] [Related]
3. [Therapeutic effects of peripheral blood stem cell transplantation following combination chemotherapy using ranimustine, cytarabine, etoposide and cyclophosphamide for patients with hematological malignancies].
Yamane T; Ohta T; Kou KR; Hashimoto S; Takekawa K; Hirai N; Tanaka K; Hasuike T; Hirai M; Ohta K
Gan To Kagaku Ryoho; 1994 May; 21(6):903-6. PubMed ID: 7910450
[No Abstract] [Full Text] [Related]
4. Use and Effectiveness of Gonadotropin-Releasing Hormone Agonists for Prophylactic Menstrual Suppression in Postmenarchal Women Who Undergo Hematopoietic Cell Transplantation.
Poorvu PD; Barton SE; Duncan CN; London WB; Laufer MR; Lehmann LE; Marcus KJ
J Pediatr Adolesc Gynecol; 2016 Jun; 29(3):265-8. PubMed ID: 26506031
[TBL] [Abstract][Full Text] [Related]
5. Uterine bleeding during high-dose chemotherapy and hematopoietic stem cell transplantation: a perfect storm.
Jones KP
Obstet Gynecol; 2013 Feb; 121(2 Pt 2 Suppl 1):419-21. PubMed ID: 23344395
[No Abstract] [Full Text] [Related]
6. Sinusoidal obstruction syndrome/veno-occlusive disease complication in lymphoma patients treated with oxaliplatin-based regimen: A case series report.
Bernichon E; Daguenet E; Molla C; Cornillon J; Lejeune C; Casteillo F; Guyotat D; Tavernier E
Curr Res Transl Med; 2018 Nov; 66(4):107-110. PubMed ID: 29519713
[TBL] [Abstract][Full Text] [Related]
7. A Case of Pulmonary Veno-occlusive Disease Following Hepatic Veno-occlusive Disease After Autologous Hematopoietic Stem Cell Transplantation for Neuroblastoma.
Isshiki K; Shima H; Yamazaki F; Takenouchi T; Shimada H
J Pediatr Hematol Oncol; 2020 Oct; 42(7):e677-e679. PubMed ID: 31335821
[TBL] [Abstract][Full Text] [Related]
8. Predictors of therapy-related leukemia and myelodysplasia following autologous transplantation for lymphoma: an assessment of risk factors.
Krishnan A; Bhatia S; Slovak ML; Arber DA; Niland JC; Nademanee A; Fung H; Bhatia R; Kashyap A; Molina A; O'Donnell MR; Parker PA; Sniecinski I; Snyder DS; Spielberger R; Stein A; Forman SJ
Blood; 2000 Mar; 95(5):1588-93. PubMed ID: 10688812
[TBL] [Abstract][Full Text] [Related]
9. [Diagnostics and therapy of cervical lymphoma].
Bode MK; Tikkakoski T; Johansson J; Johansson K; Kariniemi J; Apaja-Sarkkinen M; Tuominen H
Duodecim; 2003; 119(2):131-4. PubMed ID: 12607428
[No Abstract] [Full Text] [Related]
10. Oral contraceptives: a cause of hyperbilirubinemia in stem cell transplant patients.
Kline RM; Fennewald L; Vore M; Bertolone SJ; Hente ML
J Pediatr Hematol Oncol; 1999; 21(5):436-40. PubMed ID: 10524461
[TBL] [Abstract][Full Text] [Related]
11. [Evaluation of selected endocrine complications in patients treated with auto- and allo-haematopoietic stem cell transplantation].
Niedzielska E; Wójcik D; Barg E; Pietras W; Sega-Pondel D; Doroszko A; Niedzielska M; Skarzyńska M; Chybicka A
Med Wieku Rozwoj; 2008; 12(3):761-6. PubMed ID: 19305027
[TBL] [Abstract][Full Text] [Related]
12. High pre-transplant serum ferritin and busulfan-thiotepa conditioning regimen as risk factors for hepatic sinusoidal obstructive syndrome after autologous stem cell transplantation in patients with malignant lymphoma.
Hwang DY; Kim SJ; Cheong JW; Kim Y; Jang JE; Lee JY; Min YH; Yang WI; Kim JS
Leuk Lymphoma; 2016; 57(1):51-7. PubMed ID: 25899401
[TBL] [Abstract][Full Text] [Related]
13. Inducing amenorrhea during bone marrow transplantation. A pilot study of leuprolide acetate.
Laufer MR; Townsend NL; Parsons KE; Brody KA; Diller LR; Emans SJ; Guinan EC
J Reprod Med; 1997 Sep; 42(9):537-41. PubMed ID: 9336747
[TBL] [Abstract][Full Text] [Related]
14. Mucositis after reduced intensity conditioning and allogeneic stem cell transplantation.
Busemann C; Wilfert H; Neumann T; Kiefer T; Dölken G; Krüger WH
Onkologie; 2011; 34(10):518-24. PubMed ID: 21985850
[TBL] [Abstract][Full Text] [Related]
15. Management of uterine bleeding during hematopoietic stem cell transplantation.
Purisch SE; Shanis D; Zerbe C; Merideth M; Cuellar-Rodriguez J; Stratton P
Obstet Gynecol; 2013 Feb; 121(2 Pt 2 Suppl 1):424-7. PubMed ID: 23344397
[TBL] [Abstract][Full Text] [Related]
16. Thiotepa cyclophosphamide followed by granulocyte colony-stimulating factor mobilized allogeneic peripheral blood cells in adults with advanced leukemia.
Bacigalupo A; Van Lint MT; Valbonesi M; Lercari G; Carlier P; Lamparelli T; Gualandi F; Occhini D; Bregante S; Valeriani A; Piaggio G; Pitto A; Benvenuto F; Figari O; De Stefano G; Caimo A; Sessarego M
Blood; 1996 Jul; 88(1):353-7. PubMed ID: 8704195
[TBL] [Abstract][Full Text] [Related]
17. Newly identified poor prognostic factors for adult T-cell leukemia-lymphoma treated with allogeneic hematopoietic stem cell transplantation.
Tokunaga M; Uto H; Takeuchi S; Nakano N; Kubota A; Tokunaga M; Takatsuka Y; Seto M; Ido A; Utsunomiya A
Leuk Lymphoma; 2017 Jan; 58(1):37-44. PubMed ID: 27654808
[TBL] [Abstract][Full Text] [Related]
18. [Role of ovarian suppression in the combined treatment of breast cancer patients in premenopause].
Shchepotin IB; Zotov AS; Liubota RV; Anikus'ko NF; Liubota II
Vopr Onkol; 2013; 59(3):397-404. PubMed ID: 23909046
[No Abstract] [Full Text] [Related]
19. High-Dose Chemotherapy and Autologous Stem Cell Transplant in Older Patients with Lymphoma.
Lahoud OB; Sauter CS; Hamlin PA; Dahi PB
Curr Oncol Rep; 2015 Sep; 17(9):42. PubMed ID: 26201264
[TBL] [Abstract][Full Text] [Related]
20. Hematopoietic stem cell transplantation in the treatment of lymphoma.
Bregni M; Siena S
Curr Opin Oncol; 1991 Oct; 3(5):838-42. PubMed ID: 1684293
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
